GLW Form 144 lists proposed sale of 27,395 common shares

Rhea-AI Filing Summary

The company submitted a Form 144 notice for proposed sales of Common Stock through UBS Financial Services Inc. The filing lists multiple equity releases with dates and quantities, including 1,688 (02/08/2025), 7,140 (04/15/2025), 10,650 (04/15/2025) and 7,917 (05/22/2026).

Key Figures

Listed quantity (table): 27,395 Listed dollar amount (table): $5,263,503.55 Restricted stock release: 1,688 shares +3 more

6 metrics

Listed quantity (table) 27,395 appears in securities table row

Listed dollar amount (table) $5,263,503.55 appears in securities table row

Restricted stock release 1,688 shares 02/08/2025

Restricted stock release 7,140 shares 04/15/2025

Performance stock release 10,650 shares 04/15/2025

Stock option release 7,917 shares 05/22/2026

Key Terms

restricted stock release, performance stock release, stock option release

3 terms

restricted stock release financial

"restricted stock release | issuer | 1,688 | 02/08/2025"

performance stock release financial

"performance stock release | issuer | 10,650 | 04/15/2025"

stock option release financial

"stock option release | issuer | 7,917 | 05/22/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the GLW Form 144 filing show?

It shows a proposed sale notice of Common Stock via UBS Financial Services Inc. The filing lists multiple scheduled equity releases and quantities dated between 02/08/2025 and 05/22/2026 that the filer intends to sell.

Which equity release dates and quantities are listed in the filing for GLW?

The filing lists specific releases: 1,688 shares on 02/08/2025, 7,140 shares on 04/15/2025, 10,650 performance shares on 04/15/2025, and 7,917 shares on 05/22/2026.

Who is the broker/dealer named in the GLW Form 144?

The filing names UBS Financial Services Inc at 1000 Harbor Blvd, Weehawken, NJ as the broker/dealer. That firm is listed in the filing's securities-to-be-sold table as the intermediary for the proposed sales.

Does the filing state where GLW common shares trade?

Yes. The filing includes an exchange label of NYSE and a date of 05/22/2026 in the securities table. The entry in the table pairs the common shares with the NYSE designation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 04:02 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001930559
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Corning Incorporated
SEC File Number	001-03247
Address of Issuer	One Riverfront Plaza Corning NEW YORK 14831
Phone	607-974-7430
Name of Person for Whose Account the Securities are To Be Sold	Jaymin Amin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	27395	5263503.55	860637825	05/22/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	02/08/2025	restricted stock release	issuer			1688	02/08/2025	n/a
common	04/15/2025	restricted stock release	issuer			7140	04/15/2025	n/a
common	04/15/2025	performance stock release	issuer			10650	04/15/2025	n/a
common	05/22/2026	stock option release	issuer			7917	05/22/2026	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	05/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Jaymin Amin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)